Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim McAlindon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Rheumatic Diseases Clinics of North America|November 8, 2003
Why are clinical trials of glucosamine no longer uniformly positive?Tim McAlindon
Arthritis & Rheumatology (Hoboken, N.J.)|June 29, 2022
ReplyCharles B Eaton, Tim McAlindon, Jeffrey Driban
Journal of Medical Internet Research|April 28, 2004
Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialisMargaret Formica, Karim Kabbara, Rachael Clark, et al.
The American Journal of Medicine|May 1, 2007
Changes in barometric pressure and ambient temperature influence osteoarthritis painTim McAlindon, Margaret Formica, Christopher H Schmid, et al.
BMJ (Clinical Research Ed.)|August 30, 2003
Conducting clinical trials over the internet: feasibility studyTim McAlindon, Margaret Formica, Karim Kabbara, et al.
Drugs & Aging|May 11, 2019
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of HarmsJean-Yves Reginster, Olivier Bruyère, Philip G Conaghan, et al.
BMC Musculoskeletal Disorders|October 12, 2010
Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisDavid J Hunter, Marilyn C Pike, Beth L Jonas, et al.
Drugs & Aging|May 11, 2019
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Germain Honvo, Raveendhara R Bannuru, Olivier Bruyère, et al.
Drugs & Aging|May 11, 2019
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-AnalysisGermain Honvo, Jean-Yves Reginster, Francois Rannou, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Rheumatic Diseases Clinics of North America|November 8, 2003
Why are clinical trials of glucosamine no longer uniformly positive?Tim McAlindon
Arthritis & Rheumatology (Hoboken, N.J.)|June 29, 2022
ReplyCharles B Eaton, Tim McAlindon, Jeffrey Driban
Journal of Medical Internet Research|April 28, 2004
Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialisMargaret Formica, Karim Kabbara, Rachael Clark, et al.
The American Journal of Medicine|May 1, 2007
Changes in barometric pressure and ambient temperature influence osteoarthritis painTim McAlindon, Margaret Formica, Christopher H Schmid, et al.
BMJ (Clinical Research Ed.)|August 30, 2003
Conducting clinical trials over the internet: feasibility studyTim McAlindon, Margaret Formica, Karim Kabbara, et al.
Drugs & Aging|May 11, 2019
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of HarmsJean-Yves Reginster, Olivier Bruyère, Philip G Conaghan, et al.
BMC Musculoskeletal Disorders|October 12, 2010
Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisDavid J Hunter, Marilyn C Pike, Beth L Jonas, et al.
Drugs & Aging|May 11, 2019
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Germain Honvo, Raveendhara R Bannuru, Olivier Bruyère, et al.
Drugs & Aging|May 11, 2019
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-AnalysisGermain Honvo, Jean-Yves Reginster, Francois Rannou, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Pageof 2